Cargando…

Longitudinal brain atrophy distribution in advanced Parkinson's disease: What makes the difference in “cognitive status” converters?

We investigated the brain atrophy distribution pattern and rate of regional atrophy change in Parkinson's disease (PD) in association with the cognitive status to identify the morphological characteristics of conversion to mild cognitive impairment (MCI) and dementia (PDD). T1‐weighted longitud...

Descripción completa

Detalles Bibliográficos
Autores principales: Gorges, Martin, Kunz, Martin S., Müller, Hans‐Peter, Liepelt‐Scarfone, Inga, Storch, Alexander, Dodel, Richard, Hilker‐Roggendorf, Rüdiger, Berg, Daniela, Kalbe, Elke, Braak, Heiko, Del Tredici, Kelly, Baudrexel, Simon, Huppertz, Hans‐Jürgen, Kassubek, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7267933/
https://www.ncbi.nlm.nih.gov/pubmed/31789477
http://dx.doi.org/10.1002/hbm.24884
_version_ 1783541507766091776
author Gorges, Martin
Kunz, Martin S.
Müller, Hans‐Peter
Liepelt‐Scarfone, Inga
Storch, Alexander
Dodel, Richard
Hilker‐Roggendorf, Rüdiger
Berg, Daniela
Kalbe, Elke
Braak, Heiko
Del Tredici, Kelly
Baudrexel, Simon
Huppertz, Hans‐Jürgen
Kassubek, Jan
author_facet Gorges, Martin
Kunz, Martin S.
Müller, Hans‐Peter
Liepelt‐Scarfone, Inga
Storch, Alexander
Dodel, Richard
Hilker‐Roggendorf, Rüdiger
Berg, Daniela
Kalbe, Elke
Braak, Heiko
Del Tredici, Kelly
Baudrexel, Simon
Huppertz, Hans‐Jürgen
Kassubek, Jan
author_sort Gorges, Martin
collection PubMed
description We investigated the brain atrophy distribution pattern and rate of regional atrophy change in Parkinson's disease (PD) in association with the cognitive status to identify the morphological characteristics of conversion to mild cognitive impairment (MCI) and dementia (PDD). T1‐weighted longitudinal 3T MRI data (up to four follow‐up assessments) from neuropsychologically well‐characterized advanced PD patients (n = 172, 8.9 years disease duration) and healthy elderly controls (n = 85) enrolled in the LANDSCAPE study were longitudinally analyzed using a linear mixed effect model and atlas‐based volumetry and cortical thickness measures. At baseline, PD patients presented with cerebral atrophy and cortical thinning including striatum, temporoparietal regions, and primary/premotor cortex. The atrophy was already observed in “cognitively normal” PD patients (PD‐N) and was considerably more pronounced in cognitively impaired PD patients. Linear mixed effect modeling revealed almost similar rates of atrophy change in PD and controls. The group comparison at baseline between those PD‐N whose cognitive performance remained stable (n = 42) and those PD‐N patients who converted to MCI/PDD (“converter” cPD‐N, n = 26) indicated suggested cortical thinning in the anterior cingulate cortex in cPD‐N patients which was correlated with cognitive performance. Our results suggest that cortical brain atrophy has been already expanded in advanced PD patients without overt cognitive deficits while atrophy progression in late disease did not differ from “normal” aging regardless of the cognitive status. It appears that cortical atrophy begins early and progresses already in the initial disease stages emphasizing the need for therapeutic interventions already at disease onset.
format Online
Article
Text
id pubmed-7267933
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-72679332020-06-12 Longitudinal brain atrophy distribution in advanced Parkinson's disease: What makes the difference in “cognitive status” converters? Gorges, Martin Kunz, Martin S. Müller, Hans‐Peter Liepelt‐Scarfone, Inga Storch, Alexander Dodel, Richard Hilker‐Roggendorf, Rüdiger Berg, Daniela Kalbe, Elke Braak, Heiko Del Tredici, Kelly Baudrexel, Simon Huppertz, Hans‐Jürgen Kassubek, Jan Hum Brain Mapp Research Articles We investigated the brain atrophy distribution pattern and rate of regional atrophy change in Parkinson's disease (PD) in association with the cognitive status to identify the morphological characteristics of conversion to mild cognitive impairment (MCI) and dementia (PDD). T1‐weighted longitudinal 3T MRI data (up to four follow‐up assessments) from neuropsychologically well‐characterized advanced PD patients (n = 172, 8.9 years disease duration) and healthy elderly controls (n = 85) enrolled in the LANDSCAPE study were longitudinally analyzed using a linear mixed effect model and atlas‐based volumetry and cortical thickness measures. At baseline, PD patients presented with cerebral atrophy and cortical thinning including striatum, temporoparietal regions, and primary/premotor cortex. The atrophy was already observed in “cognitively normal” PD patients (PD‐N) and was considerably more pronounced in cognitively impaired PD patients. Linear mixed effect modeling revealed almost similar rates of atrophy change in PD and controls. The group comparison at baseline between those PD‐N whose cognitive performance remained stable (n = 42) and those PD‐N patients who converted to MCI/PDD (“converter” cPD‐N, n = 26) indicated suggested cortical thinning in the anterior cingulate cortex in cPD‐N patients which was correlated with cognitive performance. Our results suggest that cortical brain atrophy has been already expanded in advanced PD patients without overt cognitive deficits while atrophy progression in late disease did not differ from “normal” aging regardless of the cognitive status. It appears that cortical atrophy begins early and progresses already in the initial disease stages emphasizing the need for therapeutic interventions already at disease onset. John Wiley & Sons, Inc. 2019-12-02 /pmc/articles/PMC7267933/ /pubmed/31789477 http://dx.doi.org/10.1002/hbm.24884 Text en © 2019 The Authors. Human Brain Mapping published by Wiley Periodicals, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Gorges, Martin
Kunz, Martin S.
Müller, Hans‐Peter
Liepelt‐Scarfone, Inga
Storch, Alexander
Dodel, Richard
Hilker‐Roggendorf, Rüdiger
Berg, Daniela
Kalbe, Elke
Braak, Heiko
Del Tredici, Kelly
Baudrexel, Simon
Huppertz, Hans‐Jürgen
Kassubek, Jan
Longitudinal brain atrophy distribution in advanced Parkinson's disease: What makes the difference in “cognitive status” converters?
title Longitudinal brain atrophy distribution in advanced Parkinson's disease: What makes the difference in “cognitive status” converters?
title_full Longitudinal brain atrophy distribution in advanced Parkinson's disease: What makes the difference in “cognitive status” converters?
title_fullStr Longitudinal brain atrophy distribution in advanced Parkinson's disease: What makes the difference in “cognitive status” converters?
title_full_unstemmed Longitudinal brain atrophy distribution in advanced Parkinson's disease: What makes the difference in “cognitive status” converters?
title_short Longitudinal brain atrophy distribution in advanced Parkinson's disease: What makes the difference in “cognitive status” converters?
title_sort longitudinal brain atrophy distribution in advanced parkinson's disease: what makes the difference in “cognitive status” converters?
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7267933/
https://www.ncbi.nlm.nih.gov/pubmed/31789477
http://dx.doi.org/10.1002/hbm.24884
work_keys_str_mv AT gorgesmartin longitudinalbrainatrophydistributioninadvancedparkinsonsdiseasewhatmakesthedifferenceincognitivestatusconverters
AT kunzmartins longitudinalbrainatrophydistributioninadvancedparkinsonsdiseasewhatmakesthedifferenceincognitivestatusconverters
AT mullerhanspeter longitudinalbrainatrophydistributioninadvancedparkinsonsdiseasewhatmakesthedifferenceincognitivestatusconverters
AT liepeltscarfoneinga longitudinalbrainatrophydistributioninadvancedparkinsonsdiseasewhatmakesthedifferenceincognitivestatusconverters
AT storchalexander longitudinalbrainatrophydistributioninadvancedparkinsonsdiseasewhatmakesthedifferenceincognitivestatusconverters
AT dodelrichard longitudinalbrainatrophydistributioninadvancedparkinsonsdiseasewhatmakesthedifferenceincognitivestatusconverters
AT hilkerroggendorfrudiger longitudinalbrainatrophydistributioninadvancedparkinsonsdiseasewhatmakesthedifferenceincognitivestatusconverters
AT longitudinalbrainatrophydistributioninadvancedparkinsonsdiseasewhatmakesthedifferenceincognitivestatusconverters
AT bergdaniela longitudinalbrainatrophydistributioninadvancedparkinsonsdiseasewhatmakesthedifferenceincognitivestatusconverters
AT kalbeelke longitudinalbrainatrophydistributioninadvancedparkinsonsdiseasewhatmakesthedifferenceincognitivestatusconverters
AT braakheiko longitudinalbrainatrophydistributioninadvancedparkinsonsdiseasewhatmakesthedifferenceincognitivestatusconverters
AT deltredicikelly longitudinalbrainatrophydistributioninadvancedparkinsonsdiseasewhatmakesthedifferenceincognitivestatusconverters
AT baudrexelsimon longitudinalbrainatrophydistributioninadvancedparkinsonsdiseasewhatmakesthedifferenceincognitivestatusconverters
AT huppertzhansjurgen longitudinalbrainatrophydistributioninadvancedparkinsonsdiseasewhatmakesthedifferenceincognitivestatusconverters
AT kassubekjan longitudinalbrainatrophydistributioninadvancedparkinsonsdiseasewhatmakesthedifferenceincognitivestatusconverters